Nexalis Therapeutics Limited (ASX:NX1)
Australia
· Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
At close: Mar 9, 2026
Nexalis Therapeutics Market Cap
Nexalis Therapeutics has a market cap or net worth of 5.31 million as of March 9, 2026. Its market cap has decreased by -3.44% in one year.
Market Cap
5.31M
Enterprise Value
5.62M
Revenue
761.96K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since January 11, 2017, Nexalis Therapeutics's market cap has decreased from 29.98M to 5.31M, a decrease of -82.27%. That is a compound annual growth rate of -17.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrux | 5.54M |
| Zelira Therapeutics | 5.95M |
| Vectus Biosystems | 6.68M |
| Biotron | 8.11M |
| Anatara Lifesciences | 3.48M |
| Chimeric Therapeutics | 8.84M |
| Invex Therapeutics | 9.02M |
| Immuron | 9.80M |